3.0
Summary
| Name |  CGP-42112A
|
| Synonyms | CGP 42112A (ChEBI), CGP-42112 (ChemIDplus), CGP-42112A (ChEBI), CGP42112A (ChemIDplus), N(6)-[[(phenylmethoxy)carbonyl]-L-Arg-]-N(2)-[[(pyridin-3-yl)carbonyl]-L-Tyr-]-L-Lys-L-His-L-Pro-L-Ile-OH (ChEBI), N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridine-3-carbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine (IUPAC), Nalpha-nicotinoyl-Tyr-(Nalpha-Cbz-Arg)-Lys-His-Pro-Ile (ChEBI) |
| IUPAC | N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridin-3-ylcarbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine |
| Formula | C52H69N13O11 |
| PRIMARY ID (Read more) |
CHEBI:147302 |
| Type | chemical |
| Relations | 1 |
| Pathways | SARS-CoV FIBROSIS |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Relations
| Regulator | Mechanism | target | score ℹ | |
|---|---|---|---|---|
| + | CGP-42112A | down-regulates activity 
chemical inhibition
|
AGTR2 | 0.8 |
| Publications: | 1 | Organism: | In Vitro | |
| Pathways: | SARS-CoV FIBROSIS | |||